A Singaporean research team has developed CAN-Scan (short for Cancer Scan), a next-generation precision oncology platform designed to “scan” the molecular features of each patient’s cancer. Published in Cell Reports Medicine, CAN-Scan integrates patient-derived tumor models, multi-omics profiling, and machine learning to predict disease progression and therapeutic response, with the potential to personalize treatment for colorectal cancer (CRC) patients in the future.
Machine learning predicts drug response for personalized colorectal cancer treatment
